You can explore our commitment to quality right on our Home page
Estimates carry 20% uncertainty
Administration record: Date of service, drug name, concentration, volume, route of administration, injection site, administering clinicians name and credentials, and patient response/tolerance
Commonly used medications include antacids, Histamine 2 (H2) receptor blockers, and proton pump inhibitors (PPIs)
What to watch for and how to manage If a patient presents with suspected issues with a GLP-1 RA drug, heres how to approach them: Baseline assessment
In the UK, there are specific NHS criteria: Semaglutide 2.4mg (Wegovy) : NICE technology appraisal TA875 recommends this only within specialist weight management services and for a maximum of 2 years on the NHS [2] Liraglutide 3.0mg (Saxenda) : NICE technology appraisal TA664 specifies that treatment should only continue beyond 12 weeks if you've lost at least 5% of your initial body weight Clinical trials have demonstrated that most people regain weight after stopping GLP-1 medications